1. An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer

   • Carlos Alejandro Egusquiza-Alvarez
   • Martha Robles-Flores

   Review – Cancer Research 20 April 2022 Pages: 1831 - 1854

   

2. Diet and gastric cancer risk: an umbrella review of systematic reviews and meta-analyses of prospective cohort studies

   • Shu-Jun Liu
   • Pi-Di Huang
   • Xiao-Bo Yang

   Review – Cancer Research 13 June 2022 Pages: 1855 - 1868

   

3. First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study

   • Kenichiro Kudo
   • Kazuya Nishii
   • Katsuyuki Kiura

   Original Article – Cancer Research 06 April 2022 Pages: 1869 - 1877

   

4. Expression and clinical prognostic value of CYB561 in breast cancer

   • Xiaofeng Zhou
   • GuoShuang Shen
   • Jiuda Zhao

   Original Article – Cancer Research 29 April 2022 Pages: 1879 - 1892

   

5. Immunological and nutritional predictive factors in patients receiving pembrolizumab for the first-line treatment of non-small cell lung cancer

   • Naoki Shijubou
   • Toshiyuki Sumi
   • Hirofumi Chiba

   Original Article – Cancer Research 09 April 2022 Pages: 1893 - 1901

   

6. miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification

   • Bin Han
   • Ke Xu
   • Liming Zhou

   Original Article – Cancer Research 27 April 2022 Pages: 1903 - 1918

   

7. Regulatory network identified by pulmonary transcriptome and proteome profiling reveals extensive change of tumor-related genes in microRNA-21 knockout mice

   • Ge Luan
   • Ming Wang
   • Luo Zhang

   Original Article – Cancer Research 05 May 2022 Pages: 1919 - 1929

   

8. Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary

   • De-Huan Xie
   • Zheng Wu
   • Yong Su

   Original Article – Cancer Research 29 April 2022 Pages: 1931 - 1942

   

9. Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS

   • Nicola Riccetti
   • Maria Blettner
   • Martin Eichler

   Original Article – Cancer Research Open access 24 May 2022 Pages: 1943 - 1953

   

10. A retrospective analysis using deep-learning models for prediction of survival outcome and benefit of adjuvant chemotherapy in stage II/III colorectal cancer

    • Xingyu Li
    • Jitendra Jonnagaddala
    • Xu Steven Xu

    Original Article – Cancer Research 24 March 2022 Pages: 1955 - 1963

    

11. Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis

    • Chenmeng Li
    • Bei Pan
    • Shukui Wang

    Original Article – Cancer Research 31 March 2022 Pages: 1965 - 1982

    

12. Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)

    • Muhammed Burak Demircan
    • Tina M. Schnoeder
    • Florian H. Heidel

    Original Article – Cancer Research Open access 29 March 2022 Pages: 1983 - 1990

    

13. Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2

    • Mayumi Saito
    • Aarthi Rajesh
    • Merilyn Hibma

    Original Article – Cancer Research Open access 06 April 2022 Pages: 1991 - 2002

    

14. iRECIST-based versus non-standardized free text reporting of CT scans for monitoring metastatic renal cell carcinoma: a retrospective comparison

    • Laura Schomburg
    • Amer Malouhi
    • Ulf Teichgräber

    Original Article – Cancer Research Open access 14 April 2022 Pages: 2003 - 2012

    

15. Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy

    • Elsa Maitre
    • Edouard Cornet
    • Thomas Matthes

    Original Article – Cancer Research Open access 27 April 2022 Pages: 2013 - 2022

    

16. Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer

    • Nicole M. Myer
    • Kohei Shitara
    • Wilko Weichert

    Review – Clinical Oncology 13 May 2022 Pages: 2023 - 2043

    

17. Role of ANO1 in tumors and tumor immunity

    • Haini Li
    • Zongxue Yu
    • Zongtao Liu

    Review – Clinical Oncology 26 April 2022 Pages: 2045 - 2068

    

18. Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma

    • Ha Il Kim
    • Jihye Lim
    • Ju Hyun Shim

    Original Article – Clinical Oncology 30 August 2021 Pages: 2069 - 2077

    

19. Effect of antimicrobial therapy on progression-free survival of patients with non-small cell lung cancer receiving checkpoint inhibitor- and chemotherapy

    • Mark Uhlenbruch
    • Stefan Krüger

    Original Article – Clinical Oncology 01 November 2021 Pages: 2079 - 2082

    

20. Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

    • Cécile Pochon
    • Marie Detrait
    • Marie-Thérèse Rubio

    Original Article – Clinical Oncology Open access 04 September 2021 Pages: 2083 - 2097

    

21. Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation

    • Yung-Hung Luo
    • Han Liu
    • Ping Yang

    Original Article – Clinical Oncology 26 August 2021 Pages: 2099 - 2114

    

22. Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

    • Song Chen
    • Zhiqiang Wu
    • Wenbo Guo

    Original Article – Clinical Oncology Open access 28 August 2021 Pages: 2115 - 2125

    

23. Radiotherapy for glioblastoma patients with poor performance status

    • Christina Schröder
    • Dorothee Gramatzki
    • Caroline Hertler

    Original Article – Clinical Oncology Open access 26 August 2021 Pages: 2127 - 2136

    

24. Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience

    • Sabrina Welland
    • Tiago deCastro
    • Arndt Vogel

    Original Article – Clinical Oncology Open access 26 August 2021 Pages: 2137 - 2144

    

25. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer

    • Zhiwen Pan
    • Zhixuan Fu
    • Xiaohong Xu

    Original Article – Clinical Oncology 18 September 2021 Pages: 2145 - 2151

26. Investigation of the protective effect of gel incorporating Eugenia jambolana leaf extract on 5-fluorouracil-induced oral mucositis: an animal study

    • Nilay Aksoy
    • Emine Sen
    • Bugra Ozen

    Original Article – Cancer Research 27 May 2022 Pages: 2153 - 2162

    

27. Correction: Investigation of the protective effect of gel incorporating Eugenia jambolana leaf extract on 5-fluorouracil-induced oral mucositis: an animal study

    • Nilay Aksoy
    • Emine Sen
    • Bugra Ozen

    Correction 07 July 2022 Pages: 2163 - 2163

28. Transformation of invasive lung adenocarcinoma with ALK rearrangement into pulmonary sarcomatoid carcinoma

    • Xianjin Xie
    • Xudong Chen
    • Xiaoya Feng

    Letter to the Editors 15 April 2022 Pages: 2165 - 2168